BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 350308)

  • 1. [Suppression of the intradermal hypersensitivity reaction of the delayed type by a serum fraction from patients containing leukocyte migration inhibition factor].
    Gorbach AD; Novikov DK; Gorbach IN
    Biull Eksp Biol Med; 1978 Apr; 85(4):457-60. PubMed ID: 350308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of a factor suppressing leukocyte migration in the sera of allergy patients following antigen administration].
    Gorbach AD; Novikov DK; Gorbach IN
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Apr; (4):106-10. PubMed ID: 325958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of serum fractions from cancer patients on leukocyte migration out of capillary tubes].
    Novikov DK; Shmakov AP; Borisenko ID
    Biull Eksp Biol Med; 1978 Nov; 86(11):568-72. PubMed ID: 363203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of BCG cell wall-induced delayed-type hypersensitivity by BCG pre-treatment. II. Induction of suppressor T cells by heat-killed BCG injection.
    Kato K; Yamamoto K
    Immunology; 1982 Apr; 45(4):655-61. PubMed ID: 6175566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage migration inhibition as an in vitro correlate of cutaneous delayed skin reaction. II. Investigations on BCG vaccinated guinea pigs.
    Rédei A; Keserü G; Frigyesi A
    Acta Microbiol Acad Sci Hung; 1973; 20(4):275-81. PubMed ID: 4794976
    [No Abstract]   [Full Text] [Related]  

  • 6. Delayed hypersensitivity reactions in guinea-pigs using cotton pellets; demonstration of macrophage migration inhibition activity in the cell free exudate.
    Yamamoto S; Ishikura A
    J Pathol; 1979 Jan; 127(1):1-10. PubMed ID: 381610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of antigen-dependent macrophage migration inhibition factor (MIF) from lymph draining a tuberculin reaction.
    Scott DM; McConnell I; Agomo P; Lachmann PJ
    Immunology; 1978 Apr; 34(4):591-604. PubMed ID: 363599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukocyte procoagulant activity in man: an in vitro correlate of delayed-type hypersensitivity.
    Geczy CL; Meyer PA
    J Immunol; 1982 Jan; 128(1):331-6. PubMed ID: 6172485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparability of delayed hypersensitivity in various rodents. II. Jones-Mote type hypersensitivity in guinea-pigs immunized with sheep erythrocytes and its modification by cyclophosphamide or BCG pre-treatment.
    Nomoto K; Yoshida S; Himeno K
    Immunology; 1980 Sep; 41(1):83-90. PubMed ID: 7429556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Determining hypersensitivity to antigens by computing cells migrating from capillary tubes].
    Novikov DK; Adamenko GP; Novikova VI
    Biull Eksp Biol Med; 1976 Jun; 81(6):707-10. PubMed ID: 953309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transfer of delayed type hypersensitivity in guinea pigs].
    Smogorzewska E
    Probl Med Wieku Rozwoj; 1990; 16():167-88. PubMed ID: 2152405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on mechanisms of tuberculin hypersensitivity. I. The relation between the functions of cells mediating tuberculin-type hypersensitivity (TTH) and the infiltrating cells in skin reaction site (author's transl)].
    Oyamaguchi A
    Kekkaku; 1982 Feb; 57(2):59-71. PubMed ID: 7040775
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on delayed hypersensitivity pleural exudates in guinea pigs. I. Demonstration of substances in the cell-free exudate which cause inhibition of mononuclear cell migration in vitro.
    Yamamoto S; Dunn CJ; Willoughby DA
    Immunology; 1976 Apr; 30(4):505-11. PubMed ID: 131779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The adjuvant activity of mycobacterial RNA preparations and synthetic polynucleotides for induction of delayed hypersensitivity to purified protein derivative in guinea pigs.
    Casavant CH; Youmans GP
    J Immunol; 1975 Mar; 114(3):1014-22. PubMed ID: 803534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The production of anti-guinea pig lymphokine antibody.
    Yoshida T; Bigazzi PE; Cohen S
    J Immunol; 1975 Feb; 114(2 Pt 1):688-91. PubMed ID: 1091701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Stimulation of phagocytic function by factors inhibiting leukocyte and macrophage migration in humans].
    Gankovskaia LV; Tskhovrebova AZ; Gvozdeva NA; Koval'chuk LV; Cheredeev AN
    Biull Eksp Biol Med; 1986 Aug; 102(8):210-3. PubMed ID: 3527300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production and properties of migration inhibitory factor and interferon in the circulation of mice with delayed hypersensitivity.
    Youngner JS; Salvin SB
    J Immunol; 1973 Dec; 111(6):1914-22. PubMed ID: 4356326
    [No Abstract]   [Full Text] [Related]  

  • 18. Macrophage migration inhibition as an in vitro correlate of cutaneous delayed skin reaction. I. Methodical considerations.
    Rédei A
    Acta Microbiol Acad Sci Hung; 1973; 20(4):267-73. PubMed ID: 4794975
    [No Abstract]   [Full Text] [Related]  

  • 19. Guinea pig macrophage agglutination factor is antigenically distinct from migration inhibition factor and immunoglobulin.
    Godfrey HP; Geczy CL
    J Immunol; 1978 Oct; 121(4):1428-31. PubMed ID: 359706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphokines in sensitized rats. I. Migration inhibitory factor(s) from specifically stimulated thymocytes in vitro.
    Bakker WW; Engelhart JJ; Mulder I; Hoedemaeker PJ
    Int Arch Allergy Appl Immunol; 1975; 49(4):491-503. PubMed ID: 1099009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.